Showing results (511-520 of 1,373) with videos related to
Sort By:
Pageof 138
Drug Development Research|July 14, 2012
Activity of Novel Adenine Nucleotide Derivatives as Agonists and Antagonists at Recombinant Rat P2X ReceptorsSean G Brown, Brian F King, Yong-Chul Kim, et al.Drug Development Research|May 3, 2023
Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signalingYujun Wang, Zhirong Yang, Wanglong Zhu, et al.Drug Development Research|July 28, 2020
Curcumol improves cisplatin sensitivity of human gastric cancer cells through inhibiting PI3K/AKT pathwayXiaofei Huang, Jun Qian, Lingchang Li, et al.Drug Development Research|June 30, 2012
Purification and Recognition of Recombinant Mouse P2X(1) Receptors Expressed in a Baculovirus SystemLiping Chen, James P Hardwick, Peter McPhie, et al.Drug Development Research|May 11, 2023
Novel ester tethered dihydroartemisinin-3-(oxime/thiosemicarbazide)isatin hybrids as potential anti-breast cancer agents: Synthesis, in vitro cytotoxicity and structure-activity relationshipShaohuan Liu, Shu Wang, Dan Xu, et al.Drug Development Research|January 27, 2015
The Role of Potassium Channels in the Vasodilatation Induced by Resveratrol and Naringenin in Isolated Human Umbilical VeinDragana Protić, Nebojša Radunović, Svetlana Spremović-Rađenović, et al.Drug Development Research|January 27, 2015
Thalidomide Inhibits Adhesion Molecules in Experimental Acute Pancreatitis-Associated Lung InjuryPeng Lv, Hong-Yun Li, Shu-Sheng Ji, et al.Drug Development Research|January 27, 2015
5-HT2B Receptor Antagonists Reduce Nerve Injury-Induced Tactile Allodynia and Expression of 5-HT2B ReceptorsJorge B Pineda-Farias, Isabel Velázquez-Lagunas, Paulino Barragán-Iglesias, et al.Drug Development Research|July 13, 2012
8-(3-Isothiocyanatostyryl)caffeine Is a Selective, Irreversible Inhibitor of Striatal A(2)-Adenosine ReceptorsXiao-Duo Ji, Carola Gallo-Rodriguez, Kenneth A JacobsonDrug Development Research|May 15, 2023
Synthesis, biological evaluation, and molecular docking study of chromen-linked hydrazine carbothioamides as potent α-glucosidase inhibitorsRabia Basri, Saeed Ullah, Sobia Ahsan Halim, et al.Pageof 138